glp-1 drugs alzheimer's Novo Nordisk's oral drug didn't work on as hoped, but don't call it a failure Potential Role of Glucagon-like Peptide-1

Higher doses correlate with increased GI side effects (nausea, flushing)

Both excess and deficient levels of cortisol can disrupt the methylation cycle and affect the body's ability to detoxify harmful substances

doi: 10.1146/annurev-nutr-082018-124306 108 JiaoYWuLHuntingtonNDZhangX

Written By: Pharmacally Medical News Desk Novo Nordisk presented new phase 3 data on cagrilintide, a once-weekly amylin analogue, at the European Association for the Study of Diabetes (EASD) congress which is happening in Vienna, Austria from 15 to 19 September 2025

(2017) The Roles of Insulin-Like Growth Factors in Mesenchymal Stem Cell Niche Stem Cells Int